AHA GUIDELINES Bundle (free trial)

Management of Adults With Congenital Heart Disease

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1541979

Contents of this Issue

Navigation

Page 62 of 93

63 4.3.5. Tetralogy of Fallot COR LOE Recommendations Diagnostic (cont'd) 2a B-NR 5. In adults with repaired TOF and moderate risk for future sustained ventricular tachycardia and/or SCD, invasive electrophysiolog y evaluation is reasonable to inform clinical management. 2a C-EO 6. In adults with repaired TOF in whom adequate data cannot be obtained noninvasively in the setting of an arrhythmia, heart failure, unexplained ventricular dysfunction, suspected pulmonary hypertension, residual hemodynamic lesions, or cyanosis, cardiac catheterization with angiography is reasonable for assessing hemodynamics to direct management and therapies. 2b C-LD 7. In adults with repaired TOF undergoing pulmonary valve placement (surgical or transcatheter), preprocedural invasive electrophysiolog y evaluation with programmed ventricular stimulation and 3-dimensional mapping may be considered to identify and treat latent monomorphic ventricular tachycardia substrates. 2b C-LD 8. In adults with repaired TOF, noninvasive evaluation (12-lead electrocardiography, contrast-enhanced MR imaging, and/ or CT angiography) may be considered to characterize ventricular tachycardia substrates. erapeutic 1 B-NR 9. In symptomatic adults with repaired TOF and moderate or greater pulmonary valve dysfunction,* pulmonary valve replacement (surgical or transcatheter) is recommended for relief of symptoms. 2a B-NR 10. In asymptomatic adults with repaired TOF, moderate or greater pulmonary valve dysfunction,* and at least 2 of the following— RV end-systolic volume index >80 mL/m 2 , RV end-diastolic volume ≥2x LV end-diastolic volume, RV ejection fraction ≤46%, LV ejection fraction ≤50%, or progressive decline in exercise capacity—pulmonary valve replacement (surgical or transcatheter) is reasonable for improving outcomes, including lowering risks for ventricular arrhythmias and death. 2a B-NR 11. In adults with repaired TOF and high risk (by clinical markers and/or multivariable score † ) for SCD, placement of an ICD is reasonable to prevent SCD. 2a B-NR 12. In adults with repaired TOF and appropriate ICD therapies for monomorphic ventricular tachycardia, adjunctive catheter ablation is reasonable to reduce ventricular tachyarrhythmia burden. (cont'd)

Articles in this issue

Archives of this issue

view archives of AHA GUIDELINES Bundle (free trial) - Management of Adults With Congenital Heart Disease